T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...
News-Medical.Net on MSN
Researchers uncover TRAT1's central role in T helper cell function
Researchers at the Medical University of Vienna have taken a closer look at a previously largely unknown component of the ...
(PFS) of 50% in the higher 15 mg/kg dose cohort compares favorably to historical PD-(L)1 refractory settings – All clinical responses, including a complete response, observed in the higher 15 mg/kg ...
A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA ...
An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...
The ZUMA-24 study showed outpatient axicabtagene ciloleucel (axi-cel) for DLBCL reduced hospitalization and improved safety profiles. CAR T-cell therapy for DLBCL shows promise in outpatient settings, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback